Drugstores Granted Class Status In TriCor Suit

Law360, New York (August 18, 2008, 12:00 AM EDT) -- A federal judge on Monday granted class status to drugstores and other outlets alleging that the makers of the anti-cholesterol drug TriCor prevented a generic version of the drug from reaching the market by filing a series of frivolous patent infringement lawsuits.

But the judge put on hold class certification for 18 states and the District of Columbia, which filed a similar case.

A move by Abbott Laboratories and Fournier Industrie et Sante to have both sets of litigation dismissed was denied.

Judge Sue L. Robinson...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.